Clinical Trials Browser

Phase 2 × OTHER_GOV × icotinib × Clear all

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Phase 2 Unknown

Adenocarcinoma of Lung